Cover Image

Clinical encounter length and initiation of statin therapy for primary prevention among adults with elevated atherosclerotic cardiovascular disease risk

Saved in:

Bibliographic Details
Main Authors:	Alexander R. Zheutlin (Author), Mingyuan Zhang (Author), Molly B. Conroy (Author)
Format:	Book
Published:	Elsevier, 2023-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of China's Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease
by: Miao Wang, et al.
Published: (2020)

The Risk of Atherosclerotic Cardiovascular Disease among Hyperlipidaemia Patients and Appropriateness of Statin Therapy
by: Maharani F. Iskandar, et al.
Published: (2018)

PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS
by: S. Y. Martsevich, et al.
Published: (2016)

PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS
by: S. Y. Martsevich, et al.
Published: (2016)

Patterns and gaps in guideline-directed statin use for atherosclerotic cardiovascular disease by race and ethnicity
by: Ashish Sarraju, et al.
Published: (2024)

Beyond Statins: Novel Lipid-Lowering Agents for Reducing Risk of Atherosclerotic Cardiovascular Disease
by: Teimur Kayani, et al.
Published: (2024)

Is there a benefit of aspirin therapy for primary prevention to reduce the risk of atherosclerotic cardiovascular disease in patients with elevated Lipoprotein (a)-A review of the evidence
by: Mohamad Hekmat Sukkari, et al.
Published: (2023)

UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: N. F. Puchin'yan, et al.
Published: (2015)

UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: N. F. Puchin'yan, et al.
Published: (2015)

Statin utilization and cardiovascular outcomes in a real-world primary prevention cohort of older adults
by: Aaron J. Walker, et al.
Published: (2024)

Older adult preferences regarding benefits and harms of statin and aspirin therapy for cardiovascular primary prevention
by: Frances M. Wang, et al.
Published: (2023)

Patterns of statin adherence in primary cardiovascular disease prevention during the pandemic
by: Sara Malo, et al.
Published: (2022)

Leveraging structured and unstructured electronic health record data to detect reasons for suboptimal statin therapy use in patients with atherosclerotic cardiovascular disease
by: Glenn T. Gobbel, et al.
Published: (2022)

Effect of Statins for Primary Prevention of Cardiovascular Disease According to the Fatty Liver Index
by: Joonsang Yoo, et al.
Published: (2024)

Atherosclerotic Cardiovascular Disease
Published: (2011)

Overcoming clinical inertia to improve the use of cardiovascular risk reducing therapy: A Fellow's Voice
by: Alexander R Zheutlin
Published: (2024)

Economic evaluation of statins in high-risk patients treated for primary and secondary prevention of cardiovascular disease in Greece
by: Fragoulakis V, et al.
Published: (2012)

Chest Pain, Atherosclerotic Cardiovascular Disease Risk, and Cardiology Referral in Primary Care
by: Vishaal Buch, et al.
Published: (2018)

LIPOPROTEIN(A) ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK SCORE DEVELOPMENT AND PREDICTION IN PRIMARY PREVENTION FROM REAL-WORLD DATA
by: Wenjun Fan, MD, PhD
Published: (2024)

Lipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: Eligibility, utilization, target achievement, and predictors of initiation
by: Diana N. Vikulova, et al.
Published: (2020)

Gender disparities in utilization of statins for low density lipoprotein management across the spectrum of atherosclerotic cardiovascular disease: Insights from the houston methodist cardiovascular disease learning health system registry
by: Izza Shahid, et al.
Published: (2024)

STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE
by: L. N. Malay
Published: (2015)

STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE
by: L. N. Malay
Published: (2015)

Effects of Statins for Primary Prevention in the Elderly: Recent Evidence
by: Kyu Kim, et al.
Published: (2020)

The importance of LDL-C lowering in atherosclerotic cardiovascular disease prevention: Lower for longer is better
by: Omar Mhaimeed, et al.
Published: (2024)

Novel wine in an old bottle: Preventive and therapeutic potentials of andrographolide in atherosclerotic cardiovascular diseases
by: Tingting Gou, et al.
Published: (2023)

Occurrence of Intimal Thickening in Aging Ascending Aorta as a Most Initial Marker of Atherosclerotic Changes in Cardiovascular Diseases
by: Amardeep Shivkishan Bissa, et al.
Published: (2019)

Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: Team-Based Learning
by: Asma Arabi, et al.
Published: (2015)

Atherosclerotic cardiovascular disease screening and management protocols among adult HIV clinics in Asia
by: D.C. Boettiger, et al.
Published: (2020)

OPTIMAL RANGE FOR LOW-DENSITY LIPOPROTEIN (LDL) FOR DIABETIC PATIENTS ON STATIN THERAPY FOR PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS
by: Riaz Mahmood, DO, MS
Published: (2024)

Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement
by: Nathan D. Wong, et al.
Published: (2022)

Aspirin use for primary prevention among US adults with and without elevated Lipoprotein(a)
by: Alexander C. Razavi, et al.
Published: (2024)

Oral health and atherosclerotic cardiovascular disease: A review
by: Eugenia Gianos, et al.
Published: (2021)

The impact of initial statin treatment decisions on cardiovascular outcomes in clinical care settings: estimates using the Archimedes Model
by: van Herick A, et al.
Published: (2012)

Statin therapy for preventing cardiovascular diseases in patients treated with tacrolimus after kidney transplantation
by: Han N, et al.
Published: (2017)

ESTIMATED AGGREGATE TREATMENT BENEFIT WITH ADDITION OF MULTIPLE NOVEL MEDICATIONS FOR SECONDARY PREVENTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
by: Robert W. Ariss, et al.
Published: (2021)

Estimated Aggregate Treatment Benefit With Addition of Multiple Novel Medications for Secondary Prevention of Atherosclerotic Cardiovascular Disease
by: Robert W. Ariss BS, et al.
Published: (2022)

Prevalence of cardiovascular risk factors in a nationally representative adult population with inflammatory bowel disease without atherosclerotic cardiovascular disease
by: Tanushree Agrawal, et al.
Published: (2021)

GAINING POUNDS AND APPETITE: STATIN'S DOUBLE-EDGED EFFECT ON PRIMARY PREVENTION
by: Alyssa Zaidi, MD
Published: (2024)

Atherosclerotic cardiovascular disease events among adults with high predicted risk without established risk factors
by: Nathan Kong, et al.
Published: (2024)